Epidemiological findings have indicated that elevation of serum concentration of IGF1 is related to increased risk of CRC because it can considerably increase the growth of cancer cells, suggesting evidence of the role of the IGF pathway in the risk and progression of carcinogenesis (7, 32, 61–63). Here, IGF1 is linked to colorectal carcinoma.